| Altered fractal dynamics of gait: reduced stride-interval correlations with aging and Huntington’s disease JM Hausdorff, SL Mitchell, R Firtion, CK Peng, ME Cudkowicz, JY Wei, ... Journal of applied physiology 82 (1), 262-269, 1997 | 1114 | 1997 |
| Gait variability and basal ganglia disorders: stride‐to‐stride variations of gait cycle timing in Parkinson's disease and Huntington's disease JM Hausdorff, ME Cudkowicz, R Firtion, JY Wei, AL Goldberger Movement disorders 13 (3), 428-437, 1998 | 1100 | 1998 |
| Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons BJ Wainger, E Kiskinis, C Mellin, O Wiskow, SSW Han, J Sandoe, ... Cell reports 7 (1), 1-11, 2014 | 735 | 2014 |
| An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study TM Miller, A Pestronk, W David, J Rothstein, E Simpson, SH Appel, ... The Lancet Neurology 12 (5), 435-442, 2013 | 718 | 2013 |
| Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis ME Cudkowicz, D McKenna‐Yasek, PE Sapp, W Chin, B Geller, ... Annals of Neurology: Official Journal of the American Neurological …, 1997 | 713 | 1997 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 666 | 2018 |
| Dynamic markers of altered gait rhythm in amyotrophic lateral sclerosis JM Hausdorff, A Lertratanakul, ME Cudkowicz, AL Peterson, D Kaliton, ... Journal of applied physiology, 2000 | 620 | 2000 |
| Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis HD Rosas, WJ Koroshetz, YI Chen, C Skeuse, M Vangel, ME Cudkowicz, ... Neurology 60 (10), 1615-1620, 2003 | 612 | 2003 |
| Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS TM Miller, ME Cudkowicz, A Genge, PJ Shaw, G Sobue, RC Bucelli, ... New England Journal of Medicine 387 (12), 1099-1110, 2022 | 584 | 2022 |
| Trial of sodium phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis S Paganoni, EA Macklin, S Hendrix, JD Berry, MA Elliott, S Maiser, ... New England Journal of Medicine 383 (10), 919-930, 2020 | 544 | 2020 |
| Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS O Butovsky, S Siddiqui, G Gabriely, AJ Lanser, B Dake, G Murugaiyan, ... The Journal of clinical investigation 122 (9), 3063-3087, 2012 | 539 | 2012 |
| Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS T Miller, M Cudkowicz, PJ Shaw, PM Andersen, N Atassi, RC Bucelli, ... New England Journal of Medicine 383 (2), 109-119, 2020 | 538 | 2020 |
| Rate of functional decline in Huntington’s disease K Marder, H Zhao, RH Myers, M Cudkowicz, E Kayson, K Kieburtz, ... Neurology 54 (2), 452-452, 2000 | 469 | 2000 |
| Sodium phenylbutyrate prolongs survival and regulates expression of anti‐apoptotic genes in transgenic amyotrophic lateral sclerosis mice H Ryu, K Smith, SI Camelo, I Carreras, J Lee, AH Iglesias, F Dangond, ... Journal of neurochemistry 93 (5), 1087-1098, 2005 | 444 | 2005 |
| Increased oxidative damage to DNA in ALS patients M Bogdanov, RH Brown Jr, W Matson, R Smart, D Hayden, H O’Donnell, ... Free Radical Biology and Medicine 29 (7), 652-658, 2000 | 409 | 2000 |
| Natural history of infantile‐onset spinal muscular atrophy SJ Kolb, CS Coffey, JW Yankey, K Krosschell, WD Arnold, SB Rutkove, ... Annals of neurology 82 (6), 883-891, 2017 | 405 | 2017 |
| Discovery of a biomarker and lead small molecules to target r (GGGGCC)-associated defects in c9FTD/ALS Z Su, Y Zhang, TF Gendron, PO Bauer, J Chew, WY Yang, E Fostvedt, ... Neuron 83 (5), 1043-1050, 2014 | 403 | 2014 |
| Targeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice O Butovsky, MP Jedrychowski, R Cialic, S Krasemann, G Murugaiyan, ... Annals of neurology 77 (1), 75-99, 2015 | 382 | 2015 |
| A clinical trial of creatine in ALS JM Shefner, ME Cudkowicz, D Schoenfeld, T Conrad, J Taft, M Chilton, ... Neurology 63 (9), 1656-1661, 2004 | 350 | 2004 |
| Trial of celecoxib in amyotrophic lateral sclerosis ME Cudkowicz, JM Shefner, DA Schoenfeld, H Zhang, KI Andreasson, ... Annals of neurology 60 (1), 22-31, 2006 | 342 | 2006 |
Jeremy ShefnerBarrow Neurological InstituteVerificeret mail på DignityHealth.org
